How Does Ultrasound Device Improve Healthcare?

The total size of the ultrasound devices market was at USD 6,929.7 million in 2021, and it will grow at a rate of 6.4% by the end of this decade, to reach USD 12,073.4 million by 2030.

Get the sample pages of this report: https://bit.ly/3FZyjlV

The medical device tech is transitioning in the direction of miniaturization, with transportable, lightweight devices substituting their bulky counterparts. For providing point-of-care treatment to patients, healthcare institutions are laying much emphasis on the employment of lightweight and compact devices.

Due to this, manufacturers in are introducing portable devices for facilitating improved healthcare.

Hence, the diminishment of ultrasound devices has brought about increased use in emergency and ICUs. 

Handheld devices come good for physicians in routine bedside scanning, which additionally decreases the overall cost and time related with healthcare. 

Used in deep therapy. So, compact/handheld portable ultrasound devices had a major share.

The ageing population necessitates wide-ranging care as it is susceptible to to illnesses as a result of its low levels of immunity, with the long recovery time additionally degrading its life quality. 

Diseases like diabetes and cardiac disorders are extremely prevalent in elder people as a result of their weak regenerative abilities, therefore leading to a surge in the requirement for improved diagnosis and therapy.

Ultrasonic imaging is a prevailing diagnostic tool for medical practitioners and researchers, and it is extensively acknowledged by reason of its non-invasive nature. Furthermore, the tech progressions in computing applications and transducers have transformed them and prolonged their application. 

Furthermore, device display is divided into B/W, color ultrasound of which the demand for color variants will grow with a rate of about 7% in the years to come.

In the recent past, the general imaging category dominated the ultrasound devices market with about 40%, as stated by a market research company, P&S Intelligence. 

This is as a result of the increasing obtainability of HIFU and the preference for them amongst physicians throughout tissue biopsy and the cancer treatment and  a number of other diseases.

Furthermore, end users demand for these kinds of devices is the highest amongst surgical centers, hospitals,  and diagnostics centers. This can be credited to the easy obtainability of sonography-based medical processes at these medical centers, development in in key regions, and increase in the usage of MIS diagnostic and surgical procedures here.

Europe had the most sales revenue, about 40%, in in the recent past. The development in focused ultrasound's clinical uses and the early commercialization of these devices, along with the considerable healthcare outlay across the advanced European nations, are helping the industry to grow.

It is because of the increasing elderly population across the world, the demand for ultrasound devices is on the rise, in the years to come.

Read More

Next-Generation Sequencing Market Size Will Make a Huge Impact in Near Future

The global next-generation sequencing market is growing significantly due to advances in next-generation technologies, increasing scientists and researchers’ compliance for next-generation sequencing, and low cost of next-generation sequencing methods compared to conventional sequencing methods in the industry. The unexplored next-generation sequencing market in emerging economies and increasing focus for the development of personalized medicine are creating opportunities for the global next-generation sequencing market to grow at a considerable rate in the coming years.

The advanced research and development activities by the major players are propelling the demand for cost effective and efficient next-generation sequencing platforms. However, interpretation of large volume of complex sequencing data through next-generation sequencing platforms is a major challenge in global next-generation sequencing market.

The global next-generation sequencing market is categorized as technology type, sequencing workflow, applications, and end-users. Based on technology type, the next-generation sequencing market is categorized as pyrosequencing, ion-semiconductor sequencing, sequencing by synthesis, single molecule realtime sequencing, and sequencing by ligation. The sequencing by synthesis segment leads the global next-generation sequencing market. Based on sequencing workflow, the next-generation sequencing market is categorized as next-generation pre-sequencing, next-generation sequencing platforms, and next-generation sequencing services.

Inquiry Before Purchase at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=next-generation-sequencing-market

Based on applications, the next-generation sequencing market can be categorized as diagnostics, drug discovery, animal and agriculture research, personalized medicine, and others. End-users of next-generation sequencing include academic and research institutes, biopharmaceutical and biotechnology companies, hospitals, and others. Academic and research institutes lead the global next-generation sequencing market.

Some of the major players operating in the global next-generation sequencing market are Agilent Technologies, Inc., F. Hoffmann-La Roche AG, Biomatters, Ltd., GATC Biotech AG, Illumina, Inc., Thermo Fisher Scientific, Inc., Pacific Biosciences, Oxford Nanopore Technologies, Ltd, Macrogen, Inc. among others.

Read More

Global Clinical Laboratory Services Market Rising Growth and Future Analysis

The global clinical laboratory services market is growing significantly due to the advances in diagnostic techniques, increasing incidences of chronic diseases, and increasing geriatric population. Healthcare providers’ compliance for clinical diagnostic services is increasing due to the increasing demand for reducing hospitalization time and hospital readmission rates. This in turn propels the growth of the global clinical laboratory services market. Massive unexplored clinical laboratory services market in emerging economies is creating ample opportunities for the global clinical laboratory services market to grow at a considerable rate in the coming years. Several pharmaceutical companies investing huge capital for the development of advanced clinical laboratory devices is also supporting the demand for cost effective and efficient clinical laboratory services.

The global clinical laboratory services market is categorized as clinical laboratory service providers and clinical laboratory test types. Based on clinical laboratory service providers, the clinical laboratory services market is categorized as clinic-based laboratory service providers, stand-alone laboratory service providers, and hospital-based laboratory service providers. Based on clinical laboratory test types, the clinical laboratory services market is categorized as medical microbiology and cytology laboratory tests, clinical chemistry laboratory tests, human and tumor genetics tests, and other esoteric tests.

To Learn more about this report: http://bit.ly/2MGCoPb

Some of the factors driving the growth of the global clinical laboratory services market are advances in diagnostic techniques, increasing geriatric population, increasing healthcare providers’ compliance for diagnostic test and services, and increasing investment by big biopharmaceutical companies in the clinical laboratory services market. In addition, increasing prevalence of chronic diseases and increasing healthcare expenditure are supporting the growth of the global clinical laboratory services market. However, stringent regulatory requirements and lack of skilled professionals are some of the factors inhibiting the growth of the global clinical laboratory services market to some extent.

Some of the major players operating in the global clinical laboratory services market are ARUP Laboratories, Abbott Laboratories, Bio-Reference Laboratories, Charles River Laboratories, Bioscientia Healthcare, Genoptix Medical Laboratory, Healthscope Ltd, Laboratory Corporation Of America Holdings, Labco S.A., Quest Diagnostics Inc., Spectra Laboratories, Sonic Healthcare Limited, and Genoptix Medical Laboratory.

Read More